Validation of a direct-to-PCR COVID-19 detection protocol utilizing mechanical homogenization: A model for reducing resources needed for accurate testing.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 18 05 2021
accepted: 03 08 2021
entrez: 18 8 2021
pubmed: 19 8 2021
medline: 26 8 2021
Statut: epublish

Résumé

Efficient and effective viral detection methodologies are a critical piece in the global response to COVID-19, with PCR-based nasopharyngeal and oropharyngeal swab testing serving as the current gold standard. With over 100 million confirmed cases globally, the supply chains supporting these PCR testing efforts are under a tremendous amount of stress, driving the need for innovative and accurate diagnostic solutions. Herein, the utility of a direct-to-PCR method of SARS-CoV-2 detection grounded in mechanical homogenization is examined for reducing resources needed for testing while maintaining a comparable sensitivity to the current gold standard workflow of nasopharyngeal and oropharyngeal swab testing. In a head-to-head comparison of 30 patient samples, this initial clinical validation study of the proposed homogenization-based workflow demonstrated significant agreeability with the current extraction-based method utilized while cutting the total resources needed in half.

Identifiants

pubmed: 34407126
doi: 10.1371/journal.pone.0256316
pii: PONE-D-21-16323
pmc: PMC8372900
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0256316

Subventions

Organisme : Medical Research Council
ID : MC_PC_19026
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/9
Pays : United Kingdom

Déclaration de conflit d'intérêts

Z.P.M., C.M.P., G.L.R., and R.J.N. disclose that they are all currently employed by Omni International Inc, A PerkinElmer Company in some capacity, however, none of the authors have any personal financial interests in the success or failure of the company. R.J.N. also discloses that he is the founder and CEO of Jeevan BioSciences with personal financial interests in its success or failure. All authors declare that their our competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

N Engl J Med. 2020 Jul 16;383(3):e14
pubmed: 32469477
Virol J. 2020 Aug 25;17(1):129
pubmed: 32843049
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
Nat Commun. 2021 Mar 5;12(1):1467
pubmed: 33674580
J Family Med Prim Care. 2020 Aug 25;9(8):3838-3842
pubmed: 33110776
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32102856
Pharmacotherapy. 2020 Aug;40(8):857-868
pubmed: 32643218
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
JAMA. 2020 Dec 1;324(21):2153-2154
pubmed: 33185688
Mo Med. 2020 May-Jun;117(3):184-195
pubmed: 32636542
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Front Med (Lausanne). 2021 Feb 17;8:627679
pubmed: 33681254

Auteurs

Zachary P Morehouse (ZP)

Michigan State University College of Osteopathic Medicine, East Lansing, Michigan, United States of America.
Omni International Inc, A PerkinElmer Company, Kennesaw, Georgia, United States of America.
Jeevan BioSciences, Tucker, Georgia, United States of America.

Lyson Samikwa (L)

Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi.

Caleb M Proctor (CM)

Omni International Inc, A PerkinElmer Company, Kennesaw, Georgia, United States of America.

Harry Meleke (H)

Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi.

Mercy Kamdolozi (M)

Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi.

Gabriella L Ryan (GL)

Omni International Inc, A PerkinElmer Company, Kennesaw, Georgia, United States of America.

David Chaima (D)

Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi.

Antonia Ho (A)

MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Rodney J Nash (RJ)

Omni International Inc, A PerkinElmer Company, Kennesaw, Georgia, United States of America.
Jeevan BioSciences, Tucker, Georgia, United States of America.
Department of Biology, Georgia State University, Atlanta, Georgia, United States of America.

Tonney S Nyirenda (TS)

Department of Pathology, College of Medicine, University of Malawi, Blantyre, Malawi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH